{"id":"https://openalex.org/W2480755076","doi":"https://doi.org/10.1093/med/9780195398212.003.0017","title":"Neurobiology of Substance Abuse Disorders","display_name":"Neurobiology of Substance Abuse Disorders","publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W2480755076","doi":"https://doi.org/10.1093/med/9780195398212.003.0017","mag":"2480755076"},"language":"en","primary_location":{"id":"doi:10.1093/med/9780195398212.003.0017","doi":"https://doi.org/10.1093/med/9780195398212.003.0017","is_oa":false,"landing_page_url":"https://doi.org/10.1093/med/9780195398212.003.0017","pdf_url":null,"source":{"id":"https://openalex.org/S4306463708","display_name":"Oxford University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Psychopharmacology","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4253028944","display_name":"Pediatric Psychopharmacology"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016012778","display_name":"Kathryn J. Reissner","orcid":"https://orcid.org/0009-0005-7183-2351","observed_orcids":["https://orcid.org/0009-0005-7183-2351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn J. Reissner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078035590","display_name":"Peter W. Kalivas","orcid":"https://orcid.org/0000-0001-9487-0119","observed_orcids":["https://orcid.org/0000-0001-9487-0119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter W. Kalivas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.21734587,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"237","last_page":"246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.968999981880188},{"id":"https://openalex.org/keywords/addiction","display_name":"addiction","score":0.5870000123977661},{"id":"https://openalex.org/keywords/neuroscience-of-addiction","display_name":"neurobiology of addiction","score":0.9580000042915344}],"concepts":[{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.7883918285369873},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.6533649563789368},{"id":"https://openalex.org/C3018481051","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Drugs of abuse","level":3,"score":0.5650784373283386},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5419415235519409},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5292752981185913},{"id":"https://openalex.org/C2991912374","wikidata":"https://www.wikidata.org/wiki/Q400711","display_name":"Substance use","level":2,"score":0.5288977026939392},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.45559999346733093},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.36448991298675537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3537091612815857}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/med/9780195398212.003.0017","doi":"https://doi.org/10.1093/med/9780195398212.003.0017","is_oa":false,"landing_page_url":"https://doi.org/10.1093/med/9780195398212.003.0017","pdf_url":null,"source":{"id":"https://openalex.org/S4306463708","display_name":"Oxford University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Psychopharmacology","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2496841452","https://openalex.org/W2318815237","https://openalex.org/W577855473","https://openalex.org/W2502371294","https://openalex.org/W2192392606","https://openalex.org/W4221031869","https://openalex.org/W1977009562","https://openalex.org/W2400388649","https://openalex.org/W2553201953","https://openalex.org/W2478823191"],"abstract_inverted_index":{"Chapter":[0],"17":[1],"outlines":[2],"studies":[3],"that":[4],"identify":[5],"enduring":[6],"neurobiological":[7],"changes":[8],"induced":[9],"by":[10],"drugs":[11],"of":[12,23,32,35],"abuse":[13,25],"and":[14],"look":[15],"ahead":[16],"to":[17],"potential":[18],"avenues":[19],"for":[20],"pharmacotherapeutic":[21],"treatment":[22],"substance":[24],"disorders":[26],"based":[27],"upon":[28],"the":[29,33],"emerging":[30],"understanding":[31],"neurobiology":[34],"addiction.":[36]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-08-23T00:00:00"}
